Jason Kwong

Happy to see this published. As an academic was not so concerned with genomics accreditation. As a PHL director it’s critical. Here’s some thoughts on process and importance @norelle_sherry @TheDohertyInst @UniMelbMDHS pubmed.ncbi.nlm.nih.gov/37590046/

@AnaCopaescu @JasonTrubiano @CAAR_Aus @AllergyMuhc @McGill_DOM Hamburg! Thought there were already enough things happening at the moment!

So excited to have arrived in sunny Hamburg for #EAACI2023. Also very happy to have the opportunity to share our research tomorrow #drugallergy #Penicillin @JasonTrubiano @CAAR_Aus @AllergyMuhc @McGill_DOM

The #CentreforPathogenGenomics and #GlobalHealth theme at @TheDohertyInst will be co-hosting the symposium "Pathogen genomics for global infectious diseases preparedness and response" 15 August 2023. For more details and to register visit 👉go.unimelb.edu.au/8m8s

Aztreonam-avibactam clinical trial results released. Potential addition to our armamentarium against MBL producers. pfizer.com/news/press-rel…

A comprehensive scoping review by PHd superstar @GemmaKReynolds to identify risk factors for infection in CAR-T. Standardised reporting of infections required @NCICancer @PeterMacRes . clinicalmicrobiologyandinfection.com/article/S1198-…

@TrubianoJason It’s a non-Pie Chart (non-PC) group

@kwongjc The CRAP Group?!

Starting a new special interest group: the Clinicians Revolting Against Pie-charts group

Fantastic work by @adriannamturner: unrelated rifaximin use to prevent encephalopathy in patients with liver disease can cause and drive daptomycin resistance in VRE @BenjaminHowden @tstinear @ClaireGorrie GlenCarter @TheDohertyInst #ECCMID23 #VRE

Here again are my #Top10 Infectious Diseases papers of 2022. Not in order (alphabetical by first author). Non-COVID (because >120,000 COVID papers in 2022). Have to be at least one of: Paradigm Shifting, Practice Changing or Dogma Challenging #IDtwitter 🧵

WHO guidance on pathogen genome data sharing apps.who.int/iris/bitstream…

@hktuyet Where’s the boss??!

Really appreciating that we can celebrate more in person now 🙂

@DrSimonHarris @WL_Hamilton @EsteeTorok I had the same thought, but misleading photo!

@WL_Hamilton @EsteeTorok A pseudomonas infection wouldn’t be the most immediate worry if you were bitten by a blue-ringed octopus!

@ASIDANZ @livbadiv Congrats Liv!

Announced at #ASID22, congrats to @livbadiv recipient of the @ASIDANZ $25,000 Research Grant. Her PhD project aims to define the role of the microbiome in determining infectious/immunological outcomes in immune compromised specialty patient populations. buff.ly/2A9M6UA

Come work with us @id_austin! Two great opportunities for Clinical Research Coordinators in #infectiousdiseases research. #clinicaltrials #antibioticallergy #HIV #immunology #AMS #AMR #genomics #microbiome #transplantID. Please share! austinhealth.mercury.com.au

Proud of 🆔 ⁦@id_austin DRASTIC study driving the clin samples of this 🔬 with the ⭐️ ⁦@kedzierskalab⁩ 🦠 SARS-CoV-2 infection results in immune responses in resp tract & peripheral blood that suggest mechanisms of disease severity | Nature Comms nature.com/articles/s4146…

Come work with us at @id_austin @Austin_Health ! Great role for research nurse/assistant focusing on #HIV, #virology and microbial genomics/#microbiome research. Please RT! austinhealth.mercury.com.au/ViewPosition.a…

BREAKING [Thread]: 1. SA’s first real-world data on #Pfizer’s #COVID19 jab’s protection @ #Omicron infection + hospitalisation via @Discovery_SA + @MRCza Note: This is data from the 1st 3 weeks of the outbreak, so it might change - regard it as preliminary real-world data

Omicron up close: What South Africa’s experts are actually seeing on the frontlines. Nice perspective on #omicron #COVID19 #variant from people that actually are seeing it! #IDTwitter businesstech.co.za/news/trending/…

@jennifergardy @gatesfoundation @AnitaZaidi Congrats Jen!

@qldhealthnews Congrats Krispin!

Congratulations to Dr Krispin Hajkowicz, who has been appointed Queensland’s new Chief Health Officer 👏👏 Dr Hajkowicz is an infectious diseases expert, and with his team at the RBWH, has treated more than two hundred COVID-19 patients since the start of the pandemic.